Conclusion Semaglutide effectively reduces hunger and enhances satiety by mimicking the GLP-1 hormone, making it a powerful tool for weight management
trial at 1,200 mg showed poor efficacy with only 37.5% completion rate versus 18.7% placebo
Shridharani, A
25, 2024 The Lancet, Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression, March 2026 UCHealth, Many people using GLP-1 weight loss drugs may not be eating enough nutritious food, May 19, 2025 UCLA Health, Rapid weight loss can lead to loss of muscle mass, May 1, 2024 University of Colorado, The Underappreciated Benefits of GLP-1 Receptor Agonists, Nov
Common reasons include: Sports injuries Tendon or ligament strain Joint stiffness or reduced mobility Slow recovery after surgery Chronic inflammation Skin aging and collagen loss In Miami, many patients remain physically active year-round